For Professional Clients only. Not for distribution to or to be relied upon by Retail Clients.
“Asia’s aggregate GDP surpassed that of America at the end of 2018 and a new cycle is starting. The Asian Century has begun.”Sally Macdonald
Sally Macdonald is Head of Asian Equities at Marlborough Fund Managers.
China has risen fast and accomplished much in 70 years of the People’s Republic, but nothing rises smoothly. Colossal tension besets the domestic economy and external relations. The Belt and Road Initiative has resuscitated the Silk Road and should, in time, reap trade benefits, but it has spread heavy debts.
Domestically, trade wars and restructuring are biting into an economy already slowing hard. With the official fiscal deficit already 4% of GDP (possibly up to 10% if local governments’ obligations are included), room to stimulate is limited. Debt has breached 300% of GDP and China now spends 39% of annual GDP on debt repayment, making the central bank reluctant to encourage more lending.
The rebalancing of the economy is real: China has mastered cutting edge technologies, from spaceships to 3D-printed human organs, offering phenomenal investment opportunities longer term. Shorter term? Chinese stimulus since June 2018 has equalled that of 2009, but its piecemeal nature means it has not yet hit home, and tight political control and capricious censorship do not usually raise innovation to the next level. China is rising, but the way investors can best benefit may lie elsewhere.
The real beneficiary of China’s expensive wages and harsh control, as manufacturing flees south and supply chains re-shape, is south-east Asia. Foreign direct investment flows to Thailand and Vietnam have risen over 800% and 1000% year to date respectively, accelerating development and boosting exports to the US.
Perhaps India will succeed where China has struggled. With good monsoon rains behind him, Prime Minister Narendra Modi launched a moon-shot – literally – and seized public imagination with a dramatic cut in corporate taxes and a reorganisation of public sector banks to shift business to the more efficient private sector. In tandem, the Reserve Bank of India has cut rates 110bps this year and exporters are enjoying a weaker rupee. Although India now also finds itself with a 4% national fiscal deficit (10% if the state governments are included), the drama of Modi’s intervention may have jump-started sentiment.
Asia’s aggregate GDP surpassed that of America at the end of 2018 and a new cycle is starting. The Asian Century has begun. ‘Times change and power passes.’*.
*Quotation from 12th Century Chinese poet Li Qingzhao
• Relocation of supply chains is catalysing a new economic cycle in south-east Asia, offering many opportunities
• India’s audacious approach to economic rejuvenation, coupled with good monsoon rains, looks highly promising
• Although China’s systemic slowdown will take time to resolve, it is determined to build future dominance
• Conflict between China and America is nascent and will continue overshadowing the global outlook
A version of this article was first published in Investment Week magazine.
Capital is at risk. The following is a summary only of some key items in the Prospectus and more details can be found in the Prospectuses. Investors in Protected Cell Company (PCC) must have the financial expertise and willingness to accept the risks inherent in this investment. Past performance is not a reliable indicator of current or future performance; it may not be repeated and should not be the sole factor considered when selecting funds.
It should be appreciated that the value of Shares is not guaranteed and may go down as well as up and that investors may not receive, on redemption of their Shares, the amount that they originally invested.
Investment in the Company should only be undertaken as part of a diversified investment portfolio.
Investment in the Shares should be viewed as a medium to long term investment.
Shares may not be redeemed other than on any Dealing Day.
There will not be any secondary market in the shares of the Company.
Data is as at 17/10/19.
The Cells referred to are a cell of Marlborough International Fund PCC Limited (the ‘Company’), a protected cell company incorporated in Guernsey and authorised as a Class B Collective Investment Scheme under the terms of the Protection of Investors (Bailiwick of Guernsey) law, 1987, as amended. Investment may only be made on the basis of the current Prospectus, this can be found on the website www.marlboroughinternational.gg.
Marlborough International Management Limited is incorporated in Guernsey.
Registration No. 27895. Regulated by the Guernsey Financial Services Commission. It is not protected by any investor compensation scheme.
This document may contain FTSE data. Source: FTSE International Limited (“FTSE”) FTSE 2019. “FTSE” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under licence. All rights in the FTSE indices and / or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and / or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.